Helical fixation member with chemical elution capabilities

• US 8,275,468 B2
• Filed: 06/23/2009
• Issued: 09/25/2012
• Est. Priority Date: 07/03/2008
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Foster, Arthur J., Miller, Matthew J.
• Primary Examiner(s): BOCKELMAN, MARK
• Application Number:
  US12/490,015
• Publication Number:
  US 20100004723A1
• Time in Patent Office: 1,190 Days
• Field of Search: 607/120, 607/127, 607/131
• US Class Current: 607/120
• CPC Class Codes: A61N 1/0575 with drug delivery

Abstract

The lead includes a helical fixation member coupled to the distal end of the lead body. The helical fixation member has at least one internal reservoir and a plurality of elution ports in fluid communication with the internal reservoir. A therapeutic agent composition is disposed within the internal reservoir. Additionally, the helical fixation member includes a sealed distal end to prevent coring of the cardiac tissue.

Claims

1. A medical electrical lead comprising:

a lead body including a proximal end configured to be coupled to a pulse generator and a distal end adapted to be implanted at an implantation site within a patient'"'"'s heart;

at least one conductor extending within the lead body from the proximal end to the distal end;

at least one electrode located along the lead body and operatively coupled to the at least one conductor;

a helical fixation member coupled to the distal end of the lead body and configured to engage cardiac tissue at the implantation site, the helical fixation member formed from a hollow tube defining a hollow extending through the hollow tube, an internal wall laterally dividing the hollow into a first internal reservoir in a distal region of the helical fixation member and a second internal reservoir in a proximal region of the helical fixation member, a first plurality of elution ports located along a length of the helical fixation member in fluid communication with the first internal reservoir, a second plurality of elution ports located along a length of the helical fixation member in fluid communication with the second internal reservoir and a sealed distal tip;

a first therapeutic agent composition comprising a therapeutic agent and a first carrier contained within the first internal reservoir; and

a second therapeutic agent composition comprising the therapeutic agent and a second carrier contained within the second internal reservoir;

wherein one of the first and second carriers is selected for rapid release of the therapeutic agent and the other of the first and second carriers is selected for extended release of the therapeutic agent.

2. The medical electrical lead according to claim 1, wherein the therapeutic agent comprises at least one steroid selected from the group consisting of dexamethasone, betamethasone, paramethasone, beclomethasone, clobetasol, trimcinolone, prednisone, prednisolone and derivatives thereof.

3. The medical electrical lead according to claim 1, wherein the therapeutic agent comprises dexamethasone or derivatives thereof.

4. The medical electrical lead according to claim 1, wherein the therapeutic agent comprises beclomethasone or derivatives thereof.

5. The medical electrical lead according to claim 1, wherein the first plurality of elution ports comprises a greater number of elution ports than the second plurality of elution ports.

6. The medical electrical lead according to claim 1, wherein the helical fixation member is electrically active.

7. A medical electrical lead comprising:

a lead body including a proximal end configured to be coupled to a pulse generator and a distal end adapted to be implanted at an implantation site within a patient'"'"'s heart;

at least one conductor extending within the lead body from the proximal end to the distal end;

at least one electrode located along the lead body and operatively coupled to the at least one conductor;

a helical fixation member coupled to the distal end of the lead body, the helical fixation member formed from a hollow tube defining a hollow extending longitudinally through the hollow tube, a physical barrier extending across the hollow and laterally dividing the hollow into a first internal reservoir and a second internal reservoir, a plurality of elution portions located along a length of the helical fixation member comprising a first plurality of elution ports in fluid communication with the first internal reservoir and a second plurality of elution ports in fluid communication with the second internal reservoir;

a first therapeutic agent composition disposed in the first internal reservoir, the first therapeutic agent composition comprising a first steroid disposed in a first carrier to provide an initial burst of the first steroid at the implantation site; and

a second therapeutic agent composition disposed in the second internal reservoir, the second therapeutic agent composition comprising a second steroid disposed in a second carrier to provide for extended release of the second steroid.

8. The medical electrical lead according to claim 7, wherein the helical fixation member comprises a sealed distal tip configured to engage cardiac tissue.

9. The medical electrical lead according to claim 7, wherein the helical fixation member is operatively coupled to at least one conductor and is electrically active.

10. The medical electrical lead according to claim 7, wherein the first therapeutic agent composition comprises a steroid disposed in a first carrier selected for rapid release of the steroid and the second therapeutic agent composition comprises the steroid disposed in a second carrier selected for extended release of the steroid.

11. The medical electrical lead according to claim 7, wherein the first therapeutic agent composition comprises a first steroid and the second therapeutic agent comprises a second steroid.

12. The medical electrical lead according to claim 7, wherein the first internal reservoir is located in a distal region of the helical fixation member and the second internal reservoir is located in a proximal region of the helical fixation member.

13. The medical electrical lead according to claim 7, wherein the first plurality of elution ports differ in size, shape and/or number from the second plurality of elution ports.

14. The medical electrical lead according to claim 7, wherein the first plurality of elution ports are greater in number than the second plurality of elution ports.

15. The medical electrical lead according to claim 7, wherein the helical fixation member further comprises a third internal reservoir comprising a third therapeutic agent composition disposed therein, wherein a third plurality of elution ports is in fluid communication with the third internal reservoir.